tiprankstipranks
Skye Bioscience uplists to Nasdaq Global Market
PremiumThe FlySkye Bioscience uplists to Nasdaq Global Market
16d ago
Skye Bioscience Strengthens Nasdaq Compliance with Pro Forma Balance Sheet
PremiumCompany Announcements
Skye Bioscience Strengthens Nasdaq Compliance with Pro Forma Balance Sheet
23d ago
Skye Bioscience price target raised to $20 from $12 at Piper Sandler
PremiumThe Fly
Skye Bioscience price target raised to $20 from $12 at Piper Sandler
1M ago
Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
PremiumPress ReleasesSkye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
2M ago
Skye Bioscience Nears Nasdaq Listing with Updated Finances
PremiumCompany Announcements
Skye Bioscience Nears Nasdaq Listing with Updated Finances
2M ago
Fly Insider: Skye Bioscience, Coinbase among week’s notable insider trades
PremiumThe Fly
Fly Insider: Skye Bioscience, Coinbase among week’s notable insider trades
3M ago
Skye Bioscience Strikes Deal for $50M Capital Boost
PremiumCompany AnnouncementsSkye Bioscience Strikes Deal for $50M Capital Boost
3M ago
Skye Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab
PremiumPress Releases
Skye Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab
5M ago
Skye Bioscience announces clinical development plan in obesity for nimacimab
PremiumThe Fly
Skye Bioscience announces clinical development plan in obesity for nimacimab
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100